Intelligent Bio Solutions... (INBS)
NASDAQ: INBS
· Real-Time Price · USD
1.70
-0.06 (-3.41%)
At close: Sep 10, 2025, 3:59 PM
1.70
0.00%
After-hours: Sep 10, 2025, 04:10 PM EDT
Intelligent Bio Solutions Revenue Breakdown
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Other Sales Revenue | 169.21K | 121.04K | 98.41K | 189.99K | 151.45K | 147.57K | 147.22K | 177.23K | 87.56K | 70.01K | 39.13K |
| Other Sales Revenue Growth | +39.80% | +22.99% | -48.20% | +25.45% | +2.63% | +0.24% | -16.93% | +102.40% | +25.07% | +78.92% | n/a |
Revenue by Geography
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 |
|---|---|---|---|---|---|---|---|---|
| Other Country Revenue | 31.6K | 31.43K | 31.75K | 37.92K | 330.69K | 15.2K | 91.81K | 32.86K |
| Other Country Revenue Growth | +0.55% | -1.03% | -16.26% | -88.53% | +2075.59% | -83.44% | +179.38% | n/a |
Operating Expense Breakdown
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 2.72M | 2.41M | 1.81M | 1.95M | 2.67M | 2.43M | 1.71M | 2.46M | 2.43M | 1.9M | 2.25M | 1.45M | 1.46M | 1.12M | 1M | 1.33M | 1.15M | 1.02M | 858.54K | 678.21K | 523.75K | 86.12K | 1.21M | 632.25K | 541.92K | 1.13M | 537.8K | 518.87K | 811.25K | 47.69K | 581.14K | 633.17K | 125.51K |
| Selling, General, and Administrative Revenue Growth | +12.87% | +33.11% | -7.18% | -27.03% | +10.10% | +42.29% | -30.61% | +1.03% | +28.07% | -15.41% | +54.78% | -0.81% | +30.33% | +11.84% | -24.71% | +16.26% | +12.59% | +18.57% | +26.59% | +29.49% | +508.19% | -92.87% | +91.06% | +16.67% | -51.91% | +109.56% | +3.65% | -36.04% | +1601.06% | -91.79% | -8.22% | +404.49% | n/a |
| Research and Development Revenue | 1.46M | n/a | 506.94K | 948.75K | 750.09K | 471.31K | 348.45K | 103.95K | 127.06K | 299.9K | 1.19K | 79.27K | 692.61K | 413.32K | 2.64M | 106.8K | 1.31M | 2.16M | 341.82K | 30.94K | 47.18K | -58.83K | 494.67K | 105.18K | 2.21M | 431.35K | 64.57K | 987.3K | 982.5K | 708.59K | 787.09K | 393.55K | n/a |
| Research and Development Revenue Growth | n/a | -100.00% | -46.57% | +26.48% | +59.15% | +35.26% | +235.22% | -18.19% | -57.63% | +25080.35% | -98.50% | -88.55% | +67.57% | -84.35% | +2373.04% | -91.83% | -39.40% | +530.74% | +1004.85% | -34.43% | -180.21% | -111.89% | +370.30% | -95.24% | +412.58% | +568.00% | -93.46% | +0.49% | +38.66% | -9.97% | +100.00% | n/a | n/a |